In last trading session, Aethlon Medical Inc (NASDAQ:AEMD) saw 2.34 million shares changing hands with its beta currently measuring 1.81. Company’s recent per share price level of $1.94 trading at $0.37 or 23.57% at ring of the bell on the day assigns it a market valuation of $3.90M. That closing price of AEMD’s stock is at a discount of -335.05% from its 52-week high price of $8.44 and is indicating a premium of 27.84% from its 52-week low price of $1.40.

For Aethlon Medical Inc (AEMD), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Aethlon Medical Inc (NASDAQ:AEMD) trade information

Aethlon Medical Inc’s shares saw a change of -61.34% in year-to-date performance and have moved 11.49% in past 5-day. Aethlon Medical Inc (NASDAQ:AEMD) showed a performance of -36.10% in past 30-days.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 37.58% during past 5 years.

Aethlon Medical Inc (NASDAQ:AEMD)’s Major holders

SUSQUEHANNA INTERNATIONAL GROUP, LLP is the top institutional holder at AEMD for having 36652.0 shares of worth $18278.0. And as of 2024-06-30, it was holding 0.4915 of the company’s outstanding shares.

The second largest institutional holder is TWO SIGMA SECURITIES, LLC, which was holding about 34544.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.4632 of outstanding shares, having a total worth of $17227.0.